IL110380A0 - Antiviral topical pharmaceutical compositions - Google Patents

Antiviral topical pharmaceutical compositions

Info

Publication number
IL110380A0
IL110380A0 IL11038094A IL11038094A IL110380A0 IL 110380 A0 IL110380 A0 IL 110380A0 IL 11038094 A IL11038094 A IL 11038094A IL 11038094 A IL11038094 A IL 11038094A IL 110380 A0 IL110380 A0 IL 110380A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
antiviral topical
antiviral
compositions
Prior art date
Application number
IL11038094A
Original Assignee
Agis Ind 1983 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agis Ind 1983 Ltd filed Critical Agis Ind 1983 Ltd
Priority to IL11038094A priority Critical patent/IL110380A0/en
Publication of IL110380A0 publication Critical patent/IL110380A0/en
Priority to PCT/GB1995/001696 priority patent/WO1996002244A1/en
Priority to AU29860/95A priority patent/AU2986095A/en
Priority to US08/595,872 priority patent/US5869529A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
IL11038094A 1994-07-20 1994-07-20 Antiviral topical pharmaceutical compositions IL110380A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL11038094A IL110380A0 (en) 1994-07-20 1994-07-20 Antiviral topical pharmaceutical compositions
PCT/GB1995/001696 WO1996002244A1 (en) 1994-07-20 1995-07-19 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
AU29860/95A AU2986095A (en) 1994-07-20 1995-07-19 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
US08/595,872 US5869529A (en) 1994-07-20 1996-02-06 Topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11038094A IL110380A0 (en) 1994-07-20 1994-07-20 Antiviral topical pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL110380A0 true IL110380A0 (en) 1994-10-21

Family

ID=11066363

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11038094A IL110380A0 (en) 1994-07-20 1994-07-20 Antiviral topical pharmaceutical compositions

Country Status (3)

Country Link
AU (1) AU2986095A (en)
IL (1) IL110380A0 (en)
WO (1) WO1996002244A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787490A1 (en) * 1996-01-31 1997-08-06 Agis Industries (1983) Ltd A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
JP2001527517A (en) * 1996-07-26 2001-12-25 スーザン・ピー・ペリーネ Therapeutic compositions for blood, viral and cellular diseases
US6197743B1 (en) 1996-07-26 2001-03-06 The Trustees Of Boston University Compositions and methods for the treatment of viral disorders
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6596763B1 (en) 1996-11-14 2003-07-22 Lipomedica Ehf. Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
SE520811C2 (en) * 1997-01-17 2003-08-26 Ponsus Ab Skin protection preparations containing lipophilic and hydrophilic components, method of preparation and use thereof
AU774861B2 (en) 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
DE19853487A1 (en) 1998-11-19 2000-05-25 Fumapharm Ag Muri Use of dialkyl fumarate for treating transplant rejection and autoimmune disease
JP2004523511A (en) 2001-01-12 2004-08-05 フーマファーム アーゲー Fumaric acid amides
DE10101307A1 (en) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumaric acid derivatives as NF-kappaB inhibitor
WO2003000790A1 (en) 2001-06-22 2003-01-03 Exxonmobil Chemical Patents, Inc. Metallocene-produced very low density polyethylenes or linear lowdensity polyethylenes as impact modifiers
US20030018074A1 (en) * 2001-07-06 2003-01-23 Robert Kleiman Antiviral composition and treatment method
CA2488983A1 (en) 2002-07-31 2004-02-19 Exxonmobil Chemical Patents Inc. Silane crosslinkable polyethylene
WO2004022646A1 (en) 2002-09-05 2004-03-18 Exxonmobil Chemical Patents Inc. Shrink film
CN100513458C (en) 2002-09-05 2009-07-15 埃克森美孚化学专利公司 Stretch film
EP1430891A1 (en) * 2002-12-19 2004-06-23 Elisabeth Fleischmann Oil-acid-emulsion for the treatment of joint diseases and for the stimulation of blood-circulation
US7709577B2 (en) 2005-12-07 2010-05-04 Exxonmobil Chemical Patents Inc. Process of making polymer blends
WO2007130277A1 (en) 2006-05-05 2007-11-15 Exxonmobil Chemical Patents Inc. Linear low density polymer blends and articles made therefrom
US7256240B1 (en) 2006-12-22 2007-08-14 Exxonmobil Chemical Patents Inc. Process of making polymer blends
WO2011038224A1 (en) 2009-09-24 2011-03-31 Trustees Of Boston University Methods for treating viral disorders
US8618068B2 (en) 2009-12-08 2013-12-31 Trustees Of Boston University Methods and low dose regimens for treating red blood cell disorders
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
US10316176B2 (en) 2012-02-03 2019-06-11 Exxonmobil Chemical Patents Inc. Polymer compositions and methods of making them
US9139794B2 (en) 2012-02-03 2015-09-22 Exxonmobil Chemical Patents Inc. Process for the production of polymeric compositions useful as oil modifiers
CN109135034A (en) 2012-02-03 2019-01-04 埃克森美孚化学专利公司 It can be used for the preparation method of the polymer composition of oil plant modifying agent
AU2020283590A1 (en) 2019-05-31 2022-01-20 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78168A1 (en) * 1977-09-22 1979-05-25 F Genieyz SKIN TREATMENT COMPOSITION AND PREPARATION METHOD
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4520132A (en) * 1982-09-27 1985-05-28 Pennwalt Corporation Use of undecylenic acid to treat herpes labialis
GB8603621D0 (en) * 1986-02-14 1986-03-19 Habib N Modifying lipid structure of cell membranes
DE3623862A1 (en) * 1986-07-11 1988-01-21 Schering Ag USE OF DICARBONIC ACIDS WITH 7 - 13 CARBON ATOMS OR PHYSIOLOGICALLY COMPATIBLE SALTS THEREOF FOR TOPICAL TREATMENT OF ROSAZEA
FI912955A (en) * 1990-06-25 1991-12-26 Res Found Mental Hygiene ANTIMIKROBA FETTSYRASAMMANSAETTNINGAR.
AU667549B2 (en) * 1992-06-08 1996-03-28 North West University Nitrous oxide containing dermatological composition
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Also Published As

Publication number Publication date
WO1996002244A1 (en) 1996-02-01
AU2986095A (en) 1996-02-16

Similar Documents

Publication Publication Date Title
IL110380A0 (en) Antiviral topical pharmaceutical compositions
GB9508015D0 (en) Topical pharmaceutical compositions
IL101903A0 (en) Topical pharmaceutical compositions
GB9417524D0 (en) Pharmaceutical compositions
HU9503199D0 (en) Pharmaceutical basic compositions
GB9209078D0 (en) Pharmaceutical compositions
GB9408842D0 (en) Pharmaceutical compositions for topical application
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
ZA954469B (en) Pharmaceutical compositions
GB9209874D0 (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
AU5294393A (en) Topical pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
IL118684A0 (en) Antiviral topical pharmaceutical compositions
GB2308545A (en) Pharmaceutical compositions
EP0695746A3 (en) Antiviral compounds and pharmaceutical compositions
GB9211276D0 (en) Pharmaceutical compositions
ZA905671B (en) Topical pharmaceutical compositions
HU9701232D0 (en) Topical pharmaceutical composition
GB9404457D0 (en) Pharmaceutical compositions
GB9405879D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)